Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Flow Cytometry × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Mast-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1

Interventions

Dexamethasone 12 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 venetoclax 9 fludarabine 9 pomalidomide 8 Lenalidomide 7 Gemcitabine 6 Cytarabine 6 Calcium Dobesilate 6 glofitamab 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 carfilzomib 4 Doxorubicin 4 Capecitabine 4 Azacitidine 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 belantamab mafodotin 3 atezolizumab 3 Vincristine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡